A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen

NCT00002269 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ampligen
DRUG: Zidovudine

Sponsor

HEM Research